PTC THERAPEUTICS, INC. 8-K

What Happened

• PTC Therapeutics, Inc. announced financial results for the quarter ended March 31, 2026 on May 7, 2026. The company furnished a press release as Exhibit 99.1 to the Form 8-K that contains the full announcement.
• The company will host a conference call on May 7, 2026 at 4:30 p.m. Eastern Time to review the quarter’s results and provide corporate updates; access instructions are included in the press release. The Form 8‑K was signed by CFO Pierre Gravier.

Key Details

• Filing date: May 7, 2026 (Form 8-K reporting Items 2.02 and 7.01).
• Reporting period: quarter ended March 31, 2026 (Q1 2026).
• Conference call: May 7, 2026 at 4:30 p.m. ET; details in Exhibit 99.1 (press release).
• Exhibit included: Press release dated May 7, 2026 (Exhibit 99.1); cover page in Inline XBRL (Exhibit 104).

Why It Matters

• This filing notifies investors that PTC released its quarterly financial results and will discuss them on a live call — a primary source for revenue, profit/loss, and operational updates for Q1 2026.
• Investors should review the press release (Exhibit 99.1) and listen to the call for specifics on revenue, earnings, guidance, and any program or commercial updates that could affect the stock. Note the materials in this Form 8‑K are furnished (not “filed”) and thus have limited Section 18 liability under the Exchange Act.